Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy

Clinical trial NCT07721025 · RECRUITING

Trial details

NCT number: NCT07721025
Sponsor: Lexeo Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Friedreich Ataxia Cardiomyopathy, Secondary

Start date: 2026-06-25
Primary completion: 2032-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.